Astra Industrial Group announces its Interim Financial Results for the Period Ending on 2022-06-30 ( Six Months )

ELEMENT LIST	CURRENT QUARTER	SIMILAR QUARTER FOR PREVIOUS YEAR	%CHANGE	PREVIOUS QUARTER	% CHANGE
Sales/Revenue	608,544,428	533,087,193	14.15	634,518,985	-4.09
Gross Profit (Loss)	225,761,071	205,369,678	9.93	273,877,052	-17.57
Operational Profit (Loss)	91,400,602	71,019,085	28.7	95,306,033	-4.1
Net Profit (Loss) after Zakat and Tax	243,096,412	54,599,836	345.23	74,690,225	225.47
Total Comprehensive Income	238,228,033	48,500,974	391.18	74,723,664	218.81
All figures are in (Actual) Saudi Arabia, Riyals

ELEMENT LIST	CURRENT PERIOD	SIMILAR PERIOD FOR PREVIOUS YEAR	%CHANGE
Sales/Revenue	1,243,063,413	1,127,633,052	10.24
Gross Profit (Loss)	499,638,123	463,381,862	7.82
Operational Profit (Loss)	186,706,635	188,226,158	-0.81
Net Profit (Loss) after Zakat and Tax	317,786,637	105,205,604	202.06
Total Comprehensive Income	312,951,697	86,525,793	261.69
Total Share Holders Equity (after Deducting Minority Equity)	1,644,592,701	1,352,372,354	21.61
Profit (Loss) per Share	3.97	1.32
All figures are in (Actual) Saudi Arabia, Riyals

ELEMENT LIST	EXPLANATION
The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is	Net profit increases in general due to:1. Gain from discontinued operation2. Increase in sales and gross profit in the following sectors:a) Pharmaceuticalsb) Specialty chemical
The reason of the increase (decrease) in the net profit during the current quarter compared to the previous quarter of the current year is	Net profit increases in general due to:1. Gain from discontinued operation2. Decrease in selling and distribution expenses in pharmaceuticals sector.3. Decrease in general and administrative expenses in the following sectors:a) Pharmaceuticalsb) Specialty chemicalc) OtherWhile noting that there is decrease in gross profit in the following sectors:a) Pharmaceuticalsb) Specialty chemicalc) Power and steel
The reason of the increase (decrease) in the net profit during the current period compared to the same period of the last year is	Net profit increases in general due to:1. Gain from discontinued operation2. Increase in sales and gross profit in the following sectors:a) Pharmaceuticalsb) Specialty chemical3. Decrease in other expenses in pharmaceuticals sector.4. Decrease in provision for impairment of financial assets in all sectors.While noting that there is increase in selling and distribution expenses and general and administrative expenses in all sectors.
Statement of the type of external auditor’s report	Unmodified conclusion
Reclassification of Comparison Items	Certain comparative figures for the previous period have been reclassified to be consistent with the presentation of the current period.
Additional Information	1. Net Shareholders’ Equity at the end of the period was SR1,644,232,915/- compared to SR1,407,057,157/- at the end of the similar period last year with an increase of 17%.2. With the completion of the sale of Al Anmaa during the period, the financial results and statements of Al Tanmiya were accounted for in accordance with IFRS requirements. Please refer to Note 13 of the condensed interim consolidated financial statements for further details.